Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-inflammatory agent 52 (compound 7c) is an orally active, selective COX-2 inhibitor with demonstrated anti-HT29 metastatic activity, causing periodic arrest in the S phase and G2/M phase. This agent exhibits moderate anti-inflammatory efficacy alongside a notable safety profile. Additionally, it possesses the uncommon capability of inhibiting tumor development in a mouse model, indicative of anti-cancer properties [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Anti-inflammatory agent 52 (compound 7c) is an orally active, selective COX-2 inhibitor with demonstrated anti-HT29 metastatic activity, causing periodic arrest in the S phase and G2/M phase. This agent exhibits moderate anti-inflammatory efficacy alongside a notable safety profile. Additionally, it possesses the uncommon capability of inhibiting tumor development in a mouse model, indicative of anti-cancer properties [1]. |
In vitro | Anti-inflammatory agent 53 (compound 7c) at 0.25 μM over 24 hours inhibits colony formation in HT29 cells and induces cell cycle arrest at G2/M and S phases [1]. |
In vivo | Anti-inflammatory agent 53 (compound 7c), administered orally at 50 mg/kg every other day for two weeks, effectively reduced tumor volume and weight in mice with Ehrlich's ascites carcinoma [1]. |
Molecular Weight | 434.51 |
Formula | C24H22N2O4S |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.